Share Price and Basic Stock Data
Last Updated: October 11, 2025, 1:47 am
| PEG Ratio | 1.87 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Fabino Enterprises Ltd operates within the pharmaceuticals industry, showcasing a notable, albeit fluctuating, revenue trajectory. In the fiscal year ending March 2025, the company reported sales of ₹18.00 Cr, a substantial increase from ₹6.01 Cr in FY 2024. The quarterly sales data reflects volatility, with a peak of ₹5.14 Cr in March 2024 followed by a dip to ₹4.25 Cr in September 2024. The overall trend indicates a significant recovery from lower sales of ₹1.04 Cr in September 2022 and ₹2.15 Cr in March 2022. This rebound is crucial as it aligns with the company’s efforts to stabilize its market position, especially after a challenging period characterized by lower sales figures. The fluctuating performance may raise questions about the company’s operational consistency, yet the upward trend in recent quarters suggests a potential for growth, especially as it capitalizes on recovery in demand within the pharmaceutical sector.
Profitability and Efficiency Metrics
The profitability metrics of Fabino Enterprises Ltd reveal a mixed performance landscape. The net profit for FY 2025 stood at ₹0.13 Cr, which, while an improvement from ₹0.05 Cr in FY 2024, still reflects a modest return on equity (ROE) of 3.08%. The operating profit margin (OPM) recorded a mere 0.94%, indicating challenges in maintaining profitability amidst rising expenses. The company’s interest coverage ratio (ICR) was reported at 3.08x, suggesting a stable ability to cover interest payments despite financial constraints. The cash conversion cycle (CCC) of 51.93 days is relatively efficient compared to industry norms, indicating that the company manages its working capital effectively. However, the return on capital employed (ROCE) at 7.16% could be perceived as low, potentially limiting investor confidence in the company’s ability to generate adequate returns relative to the capital invested.
Balance Sheet Strength and Financial Ratios
The balance sheet of Fabino Enterprises Ltd exhibits a moderate level of financial stability, characterized by total borrowings of ₹1.61 Cr against reserves of ₹2.19 Cr. This indicates a conservative leverage position, with a debt-to-equity ratio of 0.42x, suggesting that the company is not excessively reliant on debt financing. The current ratio of 1.46x reflects a healthy liquidity position, allowing the company to meet short-term obligations comfortably. However, the price-to-book value (P/BV) ratio of 1.22x indicates that the market values the company’s equity at a premium compared to its book value, which can signal investor optimism. Conversely, the low return on assets (ROA) of 0.34% raises concerns about the effectiveness of asset utilization. The overall financial ratios suggest a company in a transitional phase, balancing between growth opportunities and the need for improved operational efficiency.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Fabino Enterprises Ltd reveals a stable ownership structure, with promoters holding 56.82% of the company, indicating a strong commitment from the founding members. The public holds 43.18%, reflecting a diverse investor base, although the number of shareholders has decreased from 195 in March 2022 to 129 in March 2025. This decline may raise concerns about investor confidence, particularly in light of the company’s inconsistent profitability. The absence of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) suggests limited institutional interest, which may impact the company’s stock liquidity and market perception. Nevertheless, the consistent promoter holding could reassure retail investors about the company’s long-term direction. A stable shareholding structure is critical for maintaining investor confidence, especially in a sector where trust in management plays a pivotal role in driving market sentiment.
Outlook, Risks, and Final Insight
Looking ahead, Fabino Enterprises Ltd faces both opportunities and challenges. The anticipated growth in sales and improvements in profitability metrics suggest a potential recovery trajectory. However, risks remain, including fluctuating revenues and low margins, which could hinder sustainable growth. The company’s reliance on a single industry exposes it to sector-specific risks, including regulatory changes and competitive pressures. Furthermore, the declining number of shareholders could indicate waning investor confidence, which may affect capital raising efforts in the future. For investors, monitoring operational efficiency and profitability will be crucial. Should the company manage to enhance its operational efficiencies while maintaining its current growth trend, it could solidify its market position. Conversely, failure to address profitability concerns may lead to increased scrutiny from investors and analysts alike, potentially affecting its valuation in the long term.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Fabino Enterprises Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Lactose (India) Ltd | 142 Cr. | 113 | 247/84.3 | 32.4 | 46.7 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.63 Cr. | 1.90 | 4.33/1.90 | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 | |
| Gujarat Themis Biosyn Ltd | 4,887 Cr. | 449 | 479/192 | 110 | 22.8 | 0.15 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 32.8 Cr. | 44.2 | 92.2/37.2 | 8.73 | 0.00 % | 41.4 % | 14.6 % | 10.0 | |
| Gujarat Inject (Kerala) Ltd | 36.5 Cr. | 24.9 | 29.1/17.0 | 38.0 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Industry Average | 19,639.20 Cr | 1,185.06 | 56.65 | 197.01 | 0.34% | 16.24% | 14.95% | 6.10 |
Quarterly Result
| Metric | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.38 | 2.05 | 2.15 | 1.04 | 2.32 | 0.94 | 5.14 | 4.25 | 13.78 |
| Expenses | 2.15 | 2.11 | 2.00 | 1.03 | 2.30 | 0.87 | 5.10 | 4.21 | 13.65 |
| Operating Profit | 0.23 | -0.06 | 0.15 | 0.01 | 0.02 | 0.07 | 0.04 | 0.04 | 0.13 |
| OPM % | 9.66% | -2.93% | 6.98% | 0.96% | 0.86% | 7.45% | 0.78% | 0.94% | 0.94% |
| Other Income | 0.00 | 0.01 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.11 | 0.18 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.06 | 0.07 |
| Depreciation | 0.02 | 0.00 | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 | 0.04 |
| Profit before tax | 0.21 | -0.05 | 0.12 | 0.01 | 0.00 | 0.06 | 0.01 | 0.07 | 0.20 |
| Tax % | 0.00% | 0.00% | 16.67% | 0.00% | 33.33% | 0.00% | 28.57% | 55.00% | |
| Net Profit | 0.21 | -0.05 | 0.10 | 0.01 | 0.00 | 0.05 | 0.00 | 0.05 | 0.09 |
| EPS in Rs | 1.75 | -0.42 | 0.48 | 0.05 | 0.00 | 0.24 | 0.00 | 0.24 | 0.43 |
Last Updated: May 31, 2025, 6:05 am
Below is a detailed analysis of the quarterly data for Fabino Enterprises Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 13.78 Cr.. The value appears strong and on an upward trend. It has increased from 4.25 Cr. (Sep 2024) to 13.78 Cr., marking an increase of 9.53 Cr..
- For Expenses, as of Mar 2025, the value is 13.65 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.21 Cr. (Sep 2024) to 13.65 Cr., marking an increase of 9.44 Cr..
- For Operating Profit, as of Mar 2025, the value is 0.13 Cr.. The value appears strong and on an upward trend. It has increased from 0.04 Cr. (Sep 2024) to 0.13 Cr., marking an increase of 0.09 Cr..
- For OPM %, as of Mar 2025, the value is 0.94%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.94%.
- For Other Income, as of Mar 2025, the value is 0.18 Cr.. The value appears strong and on an upward trend. It has increased from 0.11 Cr. (Sep 2024) to 0.18 Cr., marking an increase of 0.07 Cr..
- For Interest, as of Mar 2025, the value is 0.07 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.06 Cr. (Sep 2024) to 0.07 Cr., marking an increase of 0.01 Cr..
- For Depreciation, as of Mar 2025, the value is 0.04 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.02 Cr. (Sep 2024) to 0.04 Cr., marking an increase of 0.02 Cr..
- For Profit before tax, as of Mar 2025, the value is 0.20 Cr.. The value appears strong and on an upward trend. It has increased from 0.07 Cr. (Sep 2024) to 0.20 Cr., marking an increase of 0.13 Cr..
- For Tax %, as of Mar 2025, the value is 55.00%. The value appears to be increasing, which may not be favorable. It has increased from 28.57% (Sep 2024) to 55.00%, marking an increase of 26.43%.
- For Net Profit, as of Mar 2025, the value is 0.09 Cr.. The value appears strong and on an upward trend. It has increased from 0.05 Cr. (Sep 2024) to 0.09 Cr., marking an increase of 0.04 Cr..
- For EPS in Rs, as of Mar 2025, the value is 0.43. The value appears strong and on an upward trend. It has increased from 0.24 (Sep 2024) to 0.43, marking an increase of 0.19.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:22 am
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Sales | 2.76 | 7.52 | 3.06 | 4.19 | 3.36 | 6.01 | 18.00 |
| Expenses | 2.44 | 7.20 | 2.99 | 4.09 | 3.33 | 5.90 | 17.83 |
| Operating Profit | 0.32 | 0.32 | 0.07 | 0.10 | 0.03 | 0.11 | 0.17 |
| OPM % | 11.59% | 4.26% | 2.29% | 2.39% | 0.89% | 1.83% | 0.94% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.00 | 0.29 |
| Interest | 0.29 | 0.20 | 0.01 | 0.01 | 0.01 | 0.02 | 0.13 |
| Depreciation | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.07 |
| Profit before tax | 0.00 | 0.10 | 0.04 | 0.07 | 0.01 | 0.06 | 0.26 |
| Tax % | 30.00% | 25.00% | 28.57% | 0.00% | 16.67% | 50.00% | |
| Net Profit | 0.00 | 0.07 | 0.03 | 0.05 | 0.01 | 0.05 | 0.13 |
| EPS in Rs | 0.00 | 4.67 | 0.25 | 0.24 | 0.05 | 0.24 | 0.62 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -57.14% | 66.67% | -80.00% | 400.00% | 160.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 123.81% | -146.67% | 480.00% | -240.00% |
Fabino Enterprises Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2020-2021 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 63% |
| TTM: | 200% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 13% |
| 3 Years: | 38% |
| TTM: | 160% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 1% |
| 1 Year: | 0% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 2% |
| 3 Years: | 2% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 3:30 pm
Balance Sheet
Last Updated: July 25, 2025, 1:19 pm
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.15 | 0.15 | 1.20 | 2.10 | 2.10 | 2.10 | 2.10 |
| Reserves | 0.45 | 0.52 | 0.10 | 2.00 | 2.01 | 2.06 | 2.19 |
| Borrowings | 2.52 | 1.08 | 0.31 | 0.05 | 0.41 | 0.84 | 1.61 |
| Other Liabilities | 5.43 | 1.83 | 0.65 | 0.48 | 0.50 | 4.50 | 7.11 |
| Total Liabilities | 8.55 | 3.58 | 2.26 | 4.63 | 5.02 | 9.50 | 13.01 |
| Fixed Assets | 0.10 | 0.08 | 0.16 | 0.17 | 0.15 | 0.24 | 0.46 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.05 |
| Other Assets | 8.45 | 3.50 | 2.10 | 4.46 | 4.87 | 9.21 | 12.50 |
| Total Assets | 8.55 | 3.58 | 2.26 | 4.63 | 5.02 | 9.50 | 13.01 |
Below is a detailed analysis of the balance sheet data for Fabino Enterprises Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 2.10 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.10 Cr..
- For Reserves, as of Mar 2025, the value is 2.19 Cr.. The value appears strong and on an upward trend. It has increased from 2.06 Cr. (Mar 2024) to 2.19 Cr., marking an increase of 0.13 Cr..
- For Borrowings, as of Mar 2025, the value is 1.61 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.84 Cr. (Mar 2024) to 1.61 Cr., marking an increase of 0.77 Cr..
- For Other Liabilities, as of Mar 2025, the value is 7.11 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.50 Cr. (Mar 2024) to 7.11 Cr., marking an increase of 2.61 Cr..
- For Total Liabilities, as of Mar 2025, the value is 13.01 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.50 Cr. (Mar 2024) to 13.01 Cr., marking an increase of 3.51 Cr..
- For Fixed Assets, as of Mar 2025, the value is 0.46 Cr.. The value appears strong and on an upward trend. It has increased from 0.24 Cr. (Mar 2024) to 0.46 Cr., marking an increase of 0.22 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 0.05 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.05 Cr..
- For Other Assets, as of Mar 2025, the value is 12.50 Cr.. The value appears strong and on an upward trend. It has increased from 9.21 Cr. (Mar 2024) to 12.50 Cr., marking an increase of 3.29 Cr..
- For Total Assets, as of Mar 2025, the value is 13.01 Cr.. The value appears strong and on an upward trend. It has increased from 9.50 Cr. (Mar 2024) to 13.01 Cr., marking an increase of 3.51 Cr..
Notably, the Reserves (2.19 Cr.) exceed the Borrowings (1.61 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Free Cash Flow | -2.20 | -0.76 | -0.24 | 0.05 | -0.38 | -0.73 | -1.44 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 338.55 | 113.09 | 158.64 | 125.44 | 274.84 | 377.75 | 177.43 |
| Inventory Days | 988.71 | 15.36 | 62.61 | 174.83 | 147.24 | 88.59 | 26.56 |
| Days Payable | 1,024.81 | 77.34 | 63.94 | 34.76 | 45.78 | 294.40 | 152.06 |
| Cash Conversion Cycle | 302.45 | 51.11 | 157.31 | 265.51 | 376.29 | 171.94 | 51.93 |
| Working Capital Days | 19.84 | 51.93 | 165.80 | 292.70 | 444.30 | 282.40 | 103.21 |
| ROCE % | 12.32% | 2.98% | 2.78% | 0.46% | 1.68% | 7.16% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 |
|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.29 | 0.17 | 0.05 |
| Diluted EPS (Rs.) | 0.29 | 0.17 | 0.05 |
| Cash EPS (Rs.) | 0.67 | 0.37 | 0.20 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 20.02 | 19.73 | 19.59 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 20.02 | 19.73 | 19.59 |
| Revenue From Operations / Share (Rs.) | 85.89 | 100.39 | 16.00 |
| PBDIT / Share (Rs.) | 1.90 | 0.62 | 0.22 |
| PBIT / Share (Rs.) | 1.51 | 0.41 | 0.07 |
| PBT / Share (Rs.) | 0.89 | 0.23 | 0.05 |
| Net Profit / Share (Rs.) | 0.29 | 0.17 | 0.05 |
| NP After MI And SOA / Share (Rs.) | 0.29 | 0.17 | 0.05 |
| PBDIT Margin (%) | 2.21 | 0.62 | 1.42 |
| PBIT Margin (%) | 1.76 | 0.41 | 0.47 |
| PBT Margin (%) | 1.04 | 0.23 | 0.36 |
| Net Profit Margin (%) | 0.33 | 0.16 | 0.32 |
| NP After MI And SOA Margin (%) | 0.33 | 0.16 | 0.32 |
| Return on Networth / Equity (%) | 1.45 | 0.86 | 0.26 |
| Return on Capital Employeed (%) | 5.29 | 1.59 | 0.35 |
| Return On Assets (%) | 0.34 | 0.23 | 0.21 |
| Long Term Debt / Equity (X) | 0.42 | 0.30 | 0.09 |
| Total Debt / Equity (X) | 0.42 | 0.30 | 0.09 |
| Asset Turnover Ratio (%) | 1.09 | 2.07 | 0.00 |
| Current Ratio (X) | 1.46 | 1.51 | 10.73 |
| Quick Ratio (X) | 1.36 | 1.37 | 8.07 |
| Inventory Turnover Ratio (X) | 14.21 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 3.08 | 3.48 | 12.01 |
| Interest Coverage Ratio (Post Tax) (X) | 1.47 | 1.95 | 3.72 |
| Enterprise Value (Cr.) | 6.69 | 9.52 | 6.46 |
| EV / Net Operating Revenue (X) | 0.37 | 0.45 | 1.92 |
| EV / EBITDA (X) | 16.78 | 72.62 | 135.37 |
| MarketCap / Net Operating Revenue (X) | 0.28 | 0.39 | 1.87 |
| Price / BV (X) | 1.22 | 2.01 | 1.53 |
| Price / Net Operating Revenue (X) | 0.28 | 0.39 | 1.88 |
| EarningsYield | 0.01 | 0.00 | 0.00 |
After reviewing the key financial ratios for Fabino Enterprises Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.29. This value is below the healthy minimum of 5. It has increased from 0.17 (Mar 24) to 0.29, marking an increase of 0.12.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.29. This value is below the healthy minimum of 5. It has increased from 0.17 (Mar 24) to 0.29, marking an increase of 0.12.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 3. It has increased from 0.37 (Mar 24) to 0.67, marking an increase of 0.30.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 20.02. It has increased from 19.73 (Mar 24) to 20.02, marking an increase of 0.29.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 20.02. It has increased from 19.73 (Mar 24) to 20.02, marking an increase of 0.29.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 85.89. It has decreased from 100.39 (Mar 24) to 85.89, marking a decrease of 14.50.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1.90. This value is below the healthy minimum of 2. It has increased from 0.62 (Mar 24) to 1.90, marking an increase of 1.28.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.51. This value is within the healthy range. It has increased from 0.41 (Mar 24) to 1.51, marking an increase of 1.10.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.89. This value is within the healthy range. It has increased from 0.23 (Mar 24) to 0.89, marking an increase of 0.66.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.29. This value is below the healthy minimum of 2. It has increased from 0.17 (Mar 24) to 0.29, marking an increase of 0.12.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.29. This value is below the healthy minimum of 2. It has increased from 0.17 (Mar 24) to 0.29, marking an increase of 0.12.
- For PBDIT Margin (%), as of Mar 25, the value is 2.21. This value is below the healthy minimum of 10. It has increased from 0.62 (Mar 24) to 2.21, marking an increase of 1.59.
- For PBIT Margin (%), as of Mar 25, the value is 1.76. This value is below the healthy minimum of 10. It has increased from 0.41 (Mar 24) to 1.76, marking an increase of 1.35.
- For PBT Margin (%), as of Mar 25, the value is 1.04. This value is below the healthy minimum of 10. It has increased from 0.23 (Mar 24) to 1.04, marking an increase of 0.81.
- For Net Profit Margin (%), as of Mar 25, the value is 0.33. This value is below the healthy minimum of 5. It has increased from 0.16 (Mar 24) to 0.33, marking an increase of 0.17.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.33. This value is below the healthy minimum of 8. It has increased from 0.16 (Mar 24) to 0.33, marking an increase of 0.17.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.45. This value is below the healthy minimum of 15. It has increased from 0.86 (Mar 24) to 1.45, marking an increase of 0.59.
- For Return on Capital Employeed (%), as of Mar 25, the value is 5.29. This value is below the healthy minimum of 10. It has increased from 1.59 (Mar 24) to 5.29, marking an increase of 3.70.
- For Return On Assets (%), as of Mar 25, the value is 0.34. This value is below the healthy minimum of 5. It has increased from 0.23 (Mar 24) to 0.34, marking an increase of 0.11.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.42. This value is within the healthy range. It has increased from 0.30 (Mar 24) to 0.42, marking an increase of 0.12.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.42. This value is within the healthy range. It has increased from 0.30 (Mar 24) to 0.42, marking an increase of 0.12.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.09. It has decreased from 2.07 (Mar 24) to 1.09, marking a decrease of 0.98.
- For Current Ratio (X), as of Mar 25, the value is 1.46. This value is below the healthy minimum of 1.5. It has decreased from 1.51 (Mar 24) to 1.46, marking a decrease of 0.05.
- For Quick Ratio (X), as of Mar 25, the value is 1.36. This value is within the healthy range. It has decreased from 1.37 (Mar 24) to 1.36, marking a decrease of 0.01.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 14.21. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 14.21, marking an increase of 14.21.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.08. This value is within the healthy range. It has decreased from 3.48 (Mar 24) to 3.08, marking a decrease of 0.40.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.47. This value is below the healthy minimum of 3. It has decreased from 1.95 (Mar 24) to 1.47, marking a decrease of 0.48.
- For Enterprise Value (Cr.), as of Mar 25, the value is 6.69. It has decreased from 9.52 (Mar 24) to 6.69, marking a decrease of 2.83.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.45 (Mar 24) to 0.37, marking a decrease of 0.08.
- For EV / EBITDA (X), as of Mar 25, the value is 16.78. This value exceeds the healthy maximum of 15. It has decreased from 72.62 (Mar 24) to 16.78, marking a decrease of 55.84.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.28. This value is below the healthy minimum of 1. It has decreased from 0.39 (Mar 24) to 0.28, marking a decrease of 0.11.
- For Price / BV (X), as of Mar 25, the value is 1.22. This value is within the healthy range. It has decreased from 2.01 (Mar 24) to 1.22, marking a decrease of 0.79.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.28. This value is below the healthy minimum of 1. It has decreased from 0.39 (Mar 24) to 0.28, marking a decrease of 0.11.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Fabino Enterprises Ltd:
- Net Profit Margin: 0.33%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 5.29% (Industry Average ROCE: 16.24%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.45% (Industry Average ROE: 14.95%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.47
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.36
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 37.2 (Industry average Stock P/E: 56.65)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.42
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.33%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Pharmaceuticals | Jeevan Vihar Extension Near, Shubham Garden, Sonipat Haryana 131001 | info@fabinolife.com www.fabinolife.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Aditya Jain | Managing Director |
| Mr. Arihant Jain | Non Executive Director |
| Mr. Sumit Malik | Non Executive Director |
| Mr. Kuldeep Singh Solanki | Independent Director |
| Mrs. Tesu Alakh | Independent Director |
| Mrs. Vandana Jain | Additional Director |
FAQ
What is the intrinsic value of Fabino Enterprises Ltd?
Fabino Enterprises Ltd's intrinsic value (as of 14 October 2025) is 19.07 which is 17.09% lower the current market price of 23.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹4.83 Cr. market cap, FY2025-2026 high/low of 39.0/22.8, reserves of ₹2.19 Cr, and liabilities of 13.01 Cr.
What is the Market Cap of Fabino Enterprises Ltd?
The Market Cap of Fabino Enterprises Ltd is 4.83 Cr..
What is the current Stock Price of Fabino Enterprises Ltd as on 14 October 2025?
The current stock price of Fabino Enterprises Ltd as on 14 October 2025 is 23.0.
What is the High / Low of Fabino Enterprises Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Fabino Enterprises Ltd stocks is 39.0/22.8.
What is the Stock P/E of Fabino Enterprises Ltd?
The Stock P/E of Fabino Enterprises Ltd is 37.2.
What is the Book Value of Fabino Enterprises Ltd?
The Book Value of Fabino Enterprises Ltd is 20.4.
What is the Dividend Yield of Fabino Enterprises Ltd?
The Dividend Yield of Fabino Enterprises Ltd is 0.00 %.
What is the ROCE of Fabino Enterprises Ltd?
The ROCE of Fabino Enterprises Ltd is 7.16 %.
What is the ROE of Fabino Enterprises Ltd?
The ROE of Fabino Enterprises Ltd is 3.08 %.
What is the Face Value of Fabino Enterprises Ltd?
The Face Value of Fabino Enterprises Ltd is 10.0.